HIPK2 and neoplasm: For example, initial research has been greatly focused on HIPK2 activating p53 through phosphorylation of Ser46, and subsequent promotion of pro-apoptotic activity, therefore HIPK2’s role as a tumour suppressor has been very well-characterized (D’Orazi et al., 2002; Hofmann et al., 2002).